SCHEMBL30764734

SCHEMBL30764734

O=C(Cc1ccc(Cl)cc1)N1CC2(CN(CCc3ccc(F)cc3)C2)C1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.54
MEN1 O00255 1/20 0.54
HSD11B1 P28845 2/20 0.51
MCHR1 Q99705 1/20 0.47
GPR183 P32249 1/20 0.45
POLB P06746 1/20 0.44
DRD2 P14416 2/20 0.43
HTR1A P08908 1/20 0.42
DRD1 P21728 1/20 0.42
DRD5 P21918 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42
HTR7 P34969 1/20 0.42
HRH1 P35367 1/20 0.42
DRD3 P35462 1/20 0.42
HTR2B P41595 1/20 0.42
KCNJ1 P48048 1/20 0.42
KCNH2 Q12809 1/20 0.42
GFER P55789 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764731 0.94 HSD11B1 (0.56) KMT2AMEN1HSD11B1MCHR1POLB
SCHEMBL30764724 0.88 HSD11B1 (0.51) KMT2AMEN1HSD11B1KCNJ1KCNH2
SCHEMBL30764754 0.88 HSD11B1 (0.46) KMT2AMEN1HSD11B1KCNH2GFER
SCHEMBL30764719 0.85 SMN1; SMN2 (0.53) HSD11B1
SCHEMBL30764706 0.85 L3MBTL1 (0.57) HSD11B1
SCHEMBL30764756 0.84 HSD11B1 (0.47) KMT2AMEN1HSD11B1MCHR1POLB
SCHEMBL30764736 0.83 HSD11B1 (0.49) HSD11B1POLBHTR2A
SCHEMBL30764749 0.81 HSD11B1 (0.49) KMT2AMEN1HSD11B1GPR183KCNH2
SCHEMBL30764764 0.81 ALDH1A1 (0.49) HSD11B1POLB
SCHEMBL30764735 0.78 HSD11B1 (0.51) KMT2AMEN1HSD11B1GPR183DRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed